Cannacord just initiated research coverage on Compass Pathways (US Psychedelics) at $80. The stock is trading at $35 which is a US$1.2 billion valuation and I’ve seen price targets up to $100.
This is a sector that is just getting started and IHL could be the first and only ASX listed company with a psychedelics program. Strap yourself in girls and boys...
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-2252
-
-
- There are more pages in this discussion • 18,208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online